otiti
media
inflamm
middl
ear
depend
upon
present
associ
symptom
durat
symptom
diagnosi
classifi
follow
acut
otiti
media
aom
infect
middl
ear
acut
onset
middleear
effus
mee
exam
presenc
sign
symptom
middleear
inflamm
treatment
failur
aom
defin
lack
improv
despit
h
appropri
antibiot
therapi
diagnosi
recurr
aom
requir
three
episod
month
four
episod
month
otiti
media
effus
ome
middleear
effus
without
sign
symptom
activ
infect
chronic
ome
come
effus
persist
month
chronic
suppur
otiti
media
csom
chronic
inflamm
middl
ear
mastoid
caviti
present
otorrhea
perfor
tympan
membran
world
health
organ
definit
requir
week
otorrhea
diagnosi
wherea
other
suggest
week
symptom
diagnost
requir
otiti
media
one
common
pediatr
diagnos
worldwid
preval
may
increas
unit
state
surveil
data
center
diseas
control
show
increas
million
offic
visit
per
year
princip
diagnosi
otiti
media
least
children
least
one
episod
aom
year
age
aom
common
reason
antibiot
prescript
children
unit
state
approxim
children
diagnos
ome
school
age
episod
resolv
spontan
children
recurr
ome
episod
last
year
longer
numer
host
environment
risk
factor
studi
associ
aom
ome
see
tabl
signific
genet
predisposit
develop
otiti
media
demonstr
twin
studi
show
herit
high
studi
examin
race
likelihood
develop
otiti
media
without
clear
consensu
csom
though
rare
develop
world
remain
major
caus
morbid
mortal
develop
world
within
certain
racial
group
unfortun
lack
consensu
definit
variabl
method
make
metaanalysi
studi
difficult
highest
preval
csom
alaska
nativ
nativ
greenland
nativ
american
australian
aborigin
children
preval
children
south
pacif
island
africa
korea
india
saudi
arabia
rel
high
preval
subregion
affect
other
highli
develop
countri
us
uk
lowest
preval
recurr
aom
associ
develop
csom
suggest
similar
risk
factor
diseas
process
antibiot
era
rate
csom
decreas
support
link
nontreat
progress
chronic
diseas
addit
identifi
risk
factor
includ
inadequ
antibiot
treatment
frequent
upper
respiratori
tract
infect
nasal
diseas
poor
live
condit
poor
access
medic
care
encourag
intervent
identifi
area
direct
impact
health
one
studi
target
improv
hous
hygien
nutrit
result
decreas
csom
maori
children
develop
otiti
media
strongli
associ
impair
structur
function
eustachian
tube
baselin
middleear
space
maintain
neg
air
pressur
rel
environ
pressur
period
reliev
open
eustachian
tube
exampl
set
yawn
chew
pressur
equal
achiev
inflamm
occur
result
otiti
media
craniofaci
anomali
distort
ear
eustachian
tube
anatomi
obviou
caus
eustachian
tube
dysfunct
howev
normal
pediatr
anatomi
also
associ
impair
pressur
equal
infant
children
eustachian
tube
short
half
length
adult
eustachian
tube
compris
highli
compliant
cartilag
posit
near
horizont
angl
oppos
adult
eustachian
tube
firm
lie
angl
relat
axial
plane
characterist
pediatr
eustachian
tube
compromis
abil
effect
ventil
middl
ear
inflamm
due
upper
respiratori
tract
infect
uri
allerg
rhiniti
gastroesophag
reflux
impair
eustachian
tube
function
addit
nasopharyng
secret
reflux
insuffl
middleear
space
serv
nidu
infect
bacteria
virus
implic
otiti
media
aom
ome
similar
associ
pathogen
wherea
csom
distinct
microbi
profil
tabl
upper
respiratori
tract
infect
import
pathogenesi
aom
aom
identifi
complic
uri
children
high
coronaviru
respiratori
syncyti
viru
rsv
adenoviru
infect
high
human
metapneumoviru
infect
studi
examin
middleear
fluid
patient
aom
virus
isol
time
alon
togeth
bacteri
otopathogen
frequent
isol
viru
type
middleear
fluid
rsv
parainfluenza
influenza
b
bacteria
isol
middleear
fluid
aom
time
histor
common
bacteria
associ
otiti
media
streptococcu
pneumonia
follow
introduct
vaccin
serotyp
pneumonia
nearli
complet
elimin
haemophilu
influenza
becom
preval
pneumonia
infect
evid
nonvaccin
serotyp
increas
fill
nich
includ
identif
multidrug
resist
serotyp
introduct
pneumococc
vaccin
undoubtedli
associ
chang
bacteri
otopathogen
aom
develop
ome
also
associ
uri
uri
lead
ome
nearli
one
quarter
time
slightli
higher
incid
set
influenza
middleear
fluid
come
previous
thought
steril
base
cultur
result
howev
advent
pcr
technolog
allow
identif
bacteri
dna
mrna
cultureneg
middleear
fluid
one
hypothesi
find
presenc
biofilm
aggreg
bacteria
grow
surfac
surround
extracellular
matrix
support
hypothesi
recent
studi
visual
biofilm
microscopi
placement
tympanostomi
tube
patient
come
although
csom
associ
recurr
aom
associ
bacteri
pathogen
differ
bacteria
reach
middl
ear
via
eustachian
tube
via
extern
ear
perfor
tympan
membran
wide
variabl
preval
pathogen
howev
pseudomona
aeruginosa
common
isol
ear
cultur
p
aeruginosa
implic
progress
destruct
middleear
mastoid
structur
unlik
aom
ome
fungi
common
pathogen
isol
ear
cultur
popul
hot
humid
region
biofilm
also
gain
attent
possibl
caus
chronic
infect
csom
boni
structur
ear
inner
ear
mucosa
tympan
membran
readili
heal
acut
infect
includ
acut
infect
perfor
without
long
term
disabl
children
histori
otiti
media
tympan
membran
abnorm
present
year
age
nearli
complet
resolv
year
age
csom
result
damag
typman
membran
ossicl
mastoid
space
lead
osteoneogenesi
boni
eros
osteiti
tempor
bone
ossicl
specif
sign
symptom
otalgia
common
complaint
children
aom
although
sensit
marker
diseas
high
posit
predict
valu
presenc
infect
specif
sign
otorrhea
follow
acut
tympan
membran
perfor
hear
loss
vertigo
nystagmu
tinnitu
ear
swell
facial
paralysi
sign
may
suggest
invas
process
within
mastoid
space
tempor
bone
respect
nonspecif
sign
symptom
fever
present
one
third
two
third
patient
aom
although
fever
may
suggest
bacteremia
altern
focal
infect
addit
nonspecif
symptom
irrit
headach
anorexia
vomit
diarrhea
ome
definit
minim
symptom
mild
hear
loss
common
complaint
symptom
underli
process
result
oropharyng
inflamm
uri
allerg
rhiniti
gastroesophag
reflux
may
present
patient
csom
present
chronic
otorrhea
may
also
signific
hear
loss
conduct
hear
loss
db
may
present
due
tympan
membran
perfor
damag
ossicl
sensorineur
hear
loss
may
also
occur
csom
associ
loss
cochlear
hair
cell
due
inflamm
although
aom
common
pediatr
problem
throughout
world
develop
intern
diagnost
criteria
prove
challeng
previou
definit
broad
without
clear
distinct
aom
ome
lack
consensu
limit
abil
studi
diagnosi
treatment
practic
american
academi
pediatr
aap
american
academi
famili
practic
aafp
publish
clinic
practic
guidelin
diagnosi
acut
otiti
media
specif
criteria
histori
acut
onset
sign
symptomspres
mee
bulg
tm
limit
absent
mobil
tm
airfluid
level
behind
tm
otorrhea
sign
symptom
middleear
inflamm
direct
erythema
tm
bullou
myring
distinct
otalgia
commonli
accept
diagnost
criteria
ome
presenc
meeno
sign
symptom
aom
aap
aafp
american
academi
otolaryngolog
head
neck
surgeri
clinic
practic
guidelin
strongli
recommend
pneumat
otoscopi
use
primari
diagnost
method
ome
assess
mee
base
grade
evid
world
health
organ
diagnost
criteria
csom
tympan
membran
perforationpurul
otorrhea
present
continu
least
two
week
support
care
import
part
aom
manag
includ
pain
fever
control
evid
use
antihistamin
decongest
treatment
aom
antibiot
choic
aom
focus
medic
efficaci
pneumonia
h
influenza
moraxella
catarrhali
amoxicillin
wide
accept
first
line
therapi
nonpenicillin
allerg
patient
howev
dosag
durat
treatment
highli
variabl
dutch
colleg
gener
practition
guidelin
support
lower
dose
therapi
mgkgday
amoxicillin
compar
aap
recommend
mgkgday
rational
higher
dose
includ
increas
drug
concentr
middl
ear
treatment
resist
strain
pneumonia
case
fever
c
sever
otalgia
aap
recommend
amoxicillinclavulan
acid
first
line
therapi
potassium
clavulan
abil
inhibit
blactamaseproduc
mani
h
influenza
catarrhali
penicillin
allerg
patient
less
consensu
recommend
includ
cephalosporin
cefdinir
cefuroxim
cefpodoxim
ceftriaxon
macrolid
azithromycin
clarithromycin
erythromycin
sulfonamid
cotrimoxazol
case
treatment
failur
aap
recommend
amoxicillinclavulan
acid
ceftriaxon
clindamycin
depend
sever
allergi
penicillin
present
indiawho
collabor
programm
also
recommend
amoxicillinclavulan
acid
well
cefaclor
although
tympanocentesi
use
sever
case
treatment
failur
aom
placement
tympanostomi
tube
reserv
children
recurr
otiti
media
children
tympanostomi
tube
aom
manifest
otorrhea
treat
ofloxacin
otic
solut
ciprofloxacindexamethason
otic
solut
recommend
durat
also
variabl
previou
accept
durat
therapi
aom
day
although
recommend
remain
younger
children
children
older
five
year
demonstr
success
therapi
five
seven
day
antibiot
older
children
may
also
success
treat
day
azithromycin
day
intramuscular
ceftriaxon
nation
guidelin
endors
watchandwait
approach
aom
antibiot
prescrib
pattern
develop
complic
must
monitor
close
aom
rate
spontan
resolut
ome
high
children
ome
develop
follow
aom
spontan
resolut
mee
month
children
incident
identifi
ome
resolut
within
month
show
improv
tympanometri
curv
time
therefor
watchandwait
approach
also
prudent
ome
period
observ
hear
assess
everi
month
addit
otoscop
evalu
pneumat
otoscopi
import
ongo
surveil
asymptomat
effus
manag
conserv
without
intervent
clear
role
medic
treatment
ome
antihistamin
decongest
indic
treatment
antibiot
corticosteroid
shown
last
effect
children
persist
effus
last
month
complic
hear
loss
development
delay
risk
development
delay
damag
tympan
membran
otalgia
balanc
problem
tympanostomi
tube
placement
may
indic
remov
middleear
effus
develop
wide
accept
follow
consensu
guidelin
may
allow
understand
observ
manag
ome
hallmark
manag
csom
treatment
infect
closur
tympan
membran
mastoidectomi
tympanoplasti
cur
limit
access
tertiari
center
offer
servic
mani
children
affect
infect
spread
deep
middl
ear
diffus
mucos
diseas
cholesteatoma
develop
patient
like
refractori
medic
therapi
alon
patient
without
evid
suppur
complic
creat
conserv
medic
manag
algorithm
focus
aural
toilet
conjunct
antibiot
treatment
topic
treatment
shown
superior
system
therapi
well
costeffect
neomycinpolymyxin
recommend
first
line
therapi
transit
quinolon
ofloxacin
ciprofloxacin
gentamicin
drainag
persist
week
ear
cultur
posit
pseudomona
drainag
resolv
regimen
patient
must
follow
closur
tympan
membran
perfor
persist
tympanoplasti
perform
goal
restor
hear
perfor
persist
otorrhea
recur
mastoidectomi
indic
hear
loss
preval
complic
otiti
media
conduct
hear
loss
commonli
due
mee
less
frequent
atelectasi
middl
ear
due
high
neg
pressur
averag
hear
loss
db
rang
db
sensorineur
hear
loss
also
present
due
increas
tension
round
window
membran
inflamm
cochlear
hair
cell
hear
loss
csom
sever
aom
ome
hear
loss
may
associ
impair
develop
speech
languag
result
poor
school
perform
tympan
membran
perfor
occur
aom
ome
tm
usual
heal
within
month
chronic
perfor
last
longer
month
tympanoplasti
indic
mastoid
although
decreas
incid
antibiot
era
common
suppur
complic
otiti
media
mastoid
ga
cell
system
connect
middl
ear
episod
otiti
media
like
result
degre
mastoid
infect
spread
periosteum
mastoid
periost
develop
present
sign
fever
otalgia
postauricular
erythema
mild
tender
possibl
anteriorinferior
displac
pinna
sever
form
mastoid
occur
infect
spread
periosteum
bone
result
osteiti
potenti
develop
subperiost
abscess
mastoid
osteiti
postauricular
erythema
tender
pronounc
pinna
clearli
displac
anteriorli
inferiorli
ct
scan
use
assess
extent
diseas
mastoid
periost
treat
parenter
antibiot
tympanocentesi
myringotomi
mastoid
osteiti
addit
requir
mastoidectomi
cholesteatoma
cystic
mass
keratin
squamou
cell
epithelium
cholesterol
middl
ear
cholesteatoma
congenit
acquir
acquir
diseas
associ
chronic
otiti
media
implant
cholesteatoma
develop
follow
traumat
perfor
tm
complic
ear
surgeri
children
common
locat
cholesteatoma
posterosuperior
quadrant
par
tensa
otoscopi
defect
tm
may
visual
white
greasi
flake
debri
sometim
foul
smell
drainag
find
otoscopi
subtl
difficult
visual
make
ct
scan
use
diagnost
tool
high
suspicion
diseas
squamou
epithelium
extend
inward
creat
expand
cystic
caviti
caus
progress
eros
ossicl
mastoid
space
tempor
bone
therefor
prompt
surgic
manag
indic
tympanosclerosi
occur
chronic
middleear
inflamm
result
trauma
tm
includ
tympanostomi
tube
placement
otoscopi
whitish
plaqu
visual
tm
nodular
deposit
submucos
layer
middl
ear
also
present
conduct
hear
loss
result
ossicl
becom
embed
deposit
suppur
labyrinth
rare
complic
aom
ome
seen
csom
affect
child
present
sudden
onset
vertigo
nauseavomit
disequilibrium
sever
sensorineur
hear
loss
facial
paralysi
occur
complic
aom
due
facial
nerv
cours
middl
ear
treatment
consist
parenter
antibiot
tympanocentesi
myringotomi
immedi
surgic
mastoidectomi
indic
children
csom
cholesteatoma
intracrani
complic
mening
epidur
abscess
subdur
empyema
focal
enceph
brain
abscess
later
sinu
thrombosi
otit
hydrocephalu
decreas
antibiot
era
remain
signific
problem
underdevelop
countri
especi
set
cholesteatoma
csom
due
spread
infect
children
present
intracrani
complic
found
one
intracrani
complic
time
diagnosi
mening
occur
due
direct
spread
infect
dura
inflamm
due
altern
intracrani
complic
abscess
concurr
infect
hematogen
spread
upper
respiratori
tract
hematogen
spread
common
etiolog
treatment
parenter
antibiot
epidur
abscess
collect
granul
tissu
pu
dura
tempor
bone
result
tempor
bone
compromis
cholesteatoma
infect
earach
lowgrad
fever
tempor
headach
may
present
well
profus
creami
pulsatil
otorrhea
mani
case
epidur
abscess
asymptomat
treatment
surgic
drainag
direct
therapi
parenter
antibiot
subdur
empyema
although
common
sinus
rare
seriou
complic
otiti
media
pu
collect
develop
subdur
space
usual
due
direct
extens
infect
present
sever
toxic
appear
fever
focal
neurolog
sign
treatment
parenter
antibiot
neurosurg
drainag
indic
focal
otit
enceph
nonsuppur
brain
inflamm
associ
chronic
otiti
media
one
associ
suppur
complic
present
may
similar
brain
abscess
necessit
mri
distinguish
two
entiti
treatment
consist
antibiot
incit
infect
brain
abscess
occur
aom
csom
cholesteatoma
infect
progress
brain
local
subdur
abscess
leptomening
otogen
brain
abscess
locat
tempor
lobe
cerebellum
depend
site
infect
invas
multipl
abscess
common
bacteria
found
abscess
common
bacteria
associ
aom
csom
sign
gener
focal
neurolog
sign
gener
appear
month
follow
acut
infect
system
sign
mayb
absent
treatment
surgic
debrid
parenter
antibiot
later
sinu
thrombosi
occur
result
mastoid
inflamm
infect
spread
though
mastoid
space
sinu
final
venou
system
lead
thrombu
format
sign
infect
sign
system
infect
increas
intracrani
pressur
sequela
septic
thromboembol
later
sinu
thrombosi
high
codiagnosi
intracrani
complic
treatment
parenter
antibiot
consensu
use
anticoagul
otit
hydrocephalu
markedli
increas
intracrani
pressur
highli
associ
later
sinu
thrombosi
otiti
media
associ
environment
factor
genet
predisposit
diseas
major
environment
associ
crowd
child
care
attend
may
difficult
impact
larg
scale
prevent
effort
due
challeng
vaccin
target
frequent
pathogen
may
effect
mean
prevent
otiti
media
introduct
show
decreas
aom
diagnosi
increas
presenc
nonvaccin
serotyp
introduct
well
develop
vaccin
nontyp
h
influenza
potenti
substanti
decreas
rate
aom
children
recurr
otiti
media
daili
antibiot
prophylaxi
reduc
probabl
develop
aom
ome
csom
continu
benefit
antibiot
stop
manag
strategi
may
benefici
high
risk
period
usual
dose
regimen
half
daili
treatment
dose
amoxicillin
sulfonamid
